CAR T Cell Therapy for MS: What We Know So Far

CAR T Cell Therapy for MS: What We Know So Far

By |

Podcast: Play in new window | Download (Duration: 23:24 — 53.6MB) | Embed

Subscribe: Apple Podcasts | Spotify | iHeartRadio | Podchaser | RSS | More

CAR T Cell Therapy for MS: What We Know So Far– Episode 207

Stephanie Buxhoeveden talks with neurologist and MS specialist Dr. Krupa Pandey about the emerging research into CAR T therapy for multiple sclerosis. They discuss how CAR T works, how it differs from current treatments, what clinical trial participation involves, and whether an immune system “reset” could one day change the way MS is treated.

Thank you to the generous support of Bristol Myers Squibb of this podcast episode.

Disclaimer: This podcast provides general educational information. Can Do MS does not endorse, promote, or recommend any product or service associated with the content of this program.

Comments are closed.